Sutro Biopharma Inc (STRO)
2.97
-0.08
(-2.62%)
USD |
NASDAQ |
Jul 02, 16:00
2.97
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Revenue (Annual): 153.73M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 153.73M |
| December 31, 2022 | 67.77M |
| December 31, 2021 | 61.88M |
| December 31, 2020 | 42.72M |
| Date | Value |
|---|---|
| December 31, 2019 | 42.74M |
| December 31, 2018 | 38.42M |
| December 31, 2017 | 51.74M |
| December 31, 2016 | 59.73M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
42.72M
Minimum
2020
153.73M
Maximum
2023
73.77M
Average
61.88M
Median
2021
Revenue (Annual) Benchmarks
| AnaptysBio Inc | 17.16M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.854M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |